Bio-Linux goes global

Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.

ALS – When the body has given up, but the brain persists

The nerve disease ALS gradually deprives the patient of control over the muscles and, eventually, also of speech. The eyes continue to function, though, and wit...

Efter amerikanska uppköpet anställs fler

I somras köptes Umeåföretaget Umandiagnostics upp av amerikanska Quanterix för 22,5 miljoner dollar. Nu anställer man fler – till kontoret i Umeå.

Collaboration in laboratory automation

The Dutch company Synchron Lab Automation developed an automated DNA extraction system with high throughput, working very closely together with Festo. As a result, customers in the seed industry can collect DNA from up to 40,000 samples per day....

Nya chefer på Xvivo

Anne-Li Sigvardsson och Andreas Wallinder rekryteras inifrån bolaget.

Boehringer tackar nej till Atheras antikropp

Athera letar nya samarbetspartners när Boehringer Ingelheim drar sig ur optionsavtalet för antikroppen PC-mab.

Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

Athera inleder fas I-studie

De första patienterna har behandlats i Atheras kliniska fas I-studie på hjärt-kärlsjukdomar.

Pharma-on-Demand

Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...

Efter positiva resultat för Valneva: ”Ansökan till EMA skickas så snart som möjligt”

Efter att ha stoppats av Storbritannien ser det nu ljusare ut för Valnevas covid-19-vaccinkandidat sedan positiva fas III-resultat presenterats. Nu väntar ansök...

Brexit looking back and looking forward

More than 3 years have passed after the vote and there is still uncertainty around the outcome although the UK December 12 election set a clearer course towards...

Brexit creeping closer – or?

In this column, lawyer Pernilla Norman, tries to sort out the different Brexit options.

Less scars with new product

A new Swedish product for post surgical scar formation enters clinical development.

Ideon - Sweden's oldest science park

Old is not synonymous with boring. Swedens oldest science park Ideon still manages to attract young companies with big ideas. The recipe for success? To continu...

Boehringer paxar antikropp

Tecknar optionsavtal med Karolinska Developments portföljbolag Athera.

Läkemedelsupptäckt med CRISPR-screening

Giulia Gaudenzi: ”Key lessons from global health research”

The world will still face major challenges in the post Covid-19 pandemic, writes Giulia Gaudenzi at the KTH Division of Nanobiotechnology at Scilifelab, in a column.

75 million for research schools

Gothenburg University, Karolinska Institutet, Linköping University and Umeå University have received SEK 75 million from the Research Council. The money will be used to build five national clinical research schools. The research schools will receive 15...

Chefen för MHRA lämnar

Ian Hudson, chef för den nationella brittiska läkemedelsmyndigheten meddelar att han lämnar posten i september nästa år.

Your partnering tool - step by step

Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!

New NO product reduces diabetic pain

The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.

EU finansierar i känsligt läge

Forskningsbolaget Athera får FP7-pengar för att ta antikropps-projekt genom toxstudier och tidig klinik.

Stärker säljteamet

Anke Mollowitz sköter Recipharms europeiska kunder.

Realtids-PCR med silverblock och utbytbara färgmoduler

qTower 3 från Analytik Jena är ett nytt realtids-PCR-system som erbjuder silverblocksprestanda och detektion med sex olika färgmoduler.